Sun Pharma

Moebius Medical based in Israel has signed an exclusive global licensing deal with India’s Sun Pharmaceutical Industries Ltd.  The deal  involves the development of MM-II, a novel pharmaceutical candidate geared for the treatment of pain in osteoarthritis. According to Israel21C “MM-II is…